Back
Phathom Pharmaceuticals, Inc. Vs. Regencell Bioscience Holdings Ltd. Industry Stock Comparison
Sell
37
PHAT
Phathom Pharmaceuticals, Inc.
Last Price:
$16.91
Seasonality Move:
-12.11%
Sell
44
RGC
Regencell Bioscience Holdings Ltd.
Last Price:
$22.91
Seasonality Move:
163.53%
Sell
37
Phathom Pharmaceuticals, Inc. (PHAT)
is a Sell
Is Phathom Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Phathom Pharmaceuticals, Inc. [PHAT] share price is $17.22. The Score for PHAT is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
PHAT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
Regencell Bioscience Holdings Ltd. (RGC)
is a Sell
Is Regencell Bioscience Holdings Ltd. a Buy, Sell or Hold?
-
The current Regencell Bioscience Holdings Ltd. [RGC] share price is $23.48. The Score for RGC is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
RGC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PHAT Stock Price Chart
What is Phathom Pharmaceuticals, Inc.'s stock price today?
-
The Phathom Pharmaceuticals, Inc. share price today is $17.22Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PHAT is experiencing selling pressure, which indicates risk of future bearish movement.
RGC Stock Price Chart
What is Regencell Bioscience Holdings Ltd.'s stock price today?
-
The Regencell Bioscience Holdings Ltd. share price today is $23.48Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RGC is experiencing slight buying pressure.
PHAT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.82 | Buy |
| Relative Strength Index (14 RSI): | 65.64 | Buy |
| Chaikin Money Flow: | -232950 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.36 - 16.72) | Buy |
| Bollinger Bands (100): | (11.24 - 15.04) | Buy |
RGC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.32 | Buy |
| Relative Strength Index (14 RSI): | 67.47 | Buy |
| Chaikin Money Flow: | 210694 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.52 - 20.84) | Buy |
| Bollinger Bands (100): | (12.49 - 18.03) | Buy |
PHAT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.09 | Buy |
| 20-day SMA: | 15.65 | Buy |
| 50-day SMA: | 14.71 | Buy |
| 200-day SMA: | 9.78 | Buy |
| 8-day EMA: | 14.99 | Buy |
| 20-day EMA: | 9.48 | Buy |
| 50-day EMA: | 4.69 | Buy |
| 200-day EMA: | 1.31 | Buy |
RGC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.52 | Buy |
| 20-day SMA: | 17.95 | Buy |
| 50-day SMA: | 15.68 | Buy |
| 200-day SMA: | 13.41 | Buy |
| 8-day EMA: | 19.45 | Buy |
| 20-day EMA: | 12.09 | Buy |
| 50-day EMA: | 5.94 | Buy |
| 200-day EMA: | 1.66 | Buy |
Phathom Pharmaceuticals, Inc. Earnings Growth & PHAT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.44 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.24 per share, and a decrease next year of $0.00 per share.
Regencell Bioscience Holdings Ltd. Earnings Growth & RGC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Phathom Pharmaceuticals, Inc. Technical Analysis
| Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Regencell Bioscience Holdings Ltd. Technical Analysis
| Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||